US2026062461A1PendingUtilityA1
Population of antibodies comprising homogeneous antibodies each having left-right asymmetric sugar chains, and method for producing same
Est. expiryJan 10, 2040(~13.4 yrs left)· nominal 20-yr term from priority
C07K 2317/52C07K 2317/41C07K 1/22C12P 21/005C07K 16/32C07K 16/065C07K 16/00
76
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A population of antibodies including homogeneous antibodies in which N-linked complex sugar chains attached to asparagine (Asn) at position 297 of CH domains of Fc regions of two heavy chains on the left and the right of each antibody are sugar chains structurally different from each other is described as well as a method of producing the population of antibodies.
Claims
exact text as granted — not AI-modified1 . A method for fractionating antibodies in a population of antibodies into a non-glycosylated antibody fraction, an antibody glycosylated at one heavy chain fraction, and an antibody glycosylated at two heavy chains fraction, comprising contacting a population of antibodies with an affinity chromatography carrier having an Fcγ receptor immobilized thereon as a ligand and thereafter recovering the non-glycosylated antibody fraction, an antibody glycosylated at one heavy chain fraction, and an antibody glycosylated at two heavy chains fraction,
wherein the elution time is shorter in the order of a non-glycosylated antibody fraction, an antibody glycosylated at one heavy chain fraction, and an antibody glycosylated at two heavy chains fractions.
2 . The method of claim 1 , wherein the population of antibodies is treated with endo-β-N-acetylglucosaminidase (ENGase) prior to the population of antibodies contacting the carrier.
3 . The method of claim 2 , wherein the ENGase is EndoS.
4 . The method of claim 2 , wherein the ENGase is selected from the group consisting of EndoS D233Q, Endo S2 D184M, Endo S2 D184Q, EndoS D233Q/Q303L, D233Q/A303L/E350Q, and Endo M N175Q, and which is modified so as to suppress sugar chain cleavage activity and improve sugar chain transfer activity.Join the waitlist — get patent alerts
Track US2026062461A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.